GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Beginning Cash Position : ₦0 Mil (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Beginning Cash Position?

GlaxoSmithKline Consumer Nigeria's Beginning Cash Position for the quarter that ended in Jun. 2023 was ₦0 Mil.

GlaxoSmithKline Consumer Nigeria's quarterly Beginning Cash Position increased from Sep. 2022 (₦12,878 Mil) to Dec. 2022 (₦18,198 Mil) but then declined from Dec. 2022 (₦18,198 Mil) to Jun. 2023 (₦0 Mil).

GlaxoSmithKline Consumer Nigeria's annual Beginning Cash Position increased from Dec. 2020 (₦3,711 Mil) to Dec. 2021 (₦12,886 Mil) but then declined from Dec. 2021 (₦12,886 Mil) to Dec. 2022 (₦12,747 Mil).

GlaxoSmithKline Consumer Nigeria Beginning Cash Position Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Beginning Cash Position Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Beginning Cash Position

Get a 7-Day Free Trial

13,309.65

3,388.94

3,710.81

12,885.58

12,746.57

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Beginning Cash Position	Get a 7-Day Free Trial															12,746.57	11,289.24	12,877.54	18,198.40	-

GlaxoSmithKline Consumer Nigeria Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

GlaxoSmithKline Consumer Nigeria Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines